As a human health care company, we don’t base R&D decisions on the size of a potential market. Instead, we focus on areas of unmet medical need.
NEUROLOGY AND ONCOLOGY PRESENT FORMIDABLE CHALLENGES
In fact, those challenges may be too daunting for some pharmaceutical companies. They may shy away from research into dementia and epilepsy. They may shun difficult cancers that don’t show a clear path to success. Solutions to such diseases may seem too hard to find. Too problematic to pursue.
While others may play it safe, we’re on a mission to overcome any and all obstacles to delivering breakthrough cures.
We will not stop until our mission is achieved.
WE’RE TACKLING SOME OF THE HARDEST-TO-TREAT NEUROLOGICAL CONDITIONS